Henlius Brings In Abbott As Another Partner In Brazil

Local Player Eurofarma Had Recently Struck A $50.5m Deal

BrazilMap_1200x675
Henlius is continuing to out-license its biosimilars • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Biosimilars

More from Products